1. Home
  2. LEXX vs COOT Comparison

LEXX vs COOT Comparison

Compare LEXX & COOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • COOT
  • Stock Information
  • Founded
  • LEXX 2004
  • COOT 2020
  • Country
  • LEXX Canada
  • COOT Australia
  • Employees
  • LEXX N/A
  • COOT N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • COOT
  • Sector
  • LEXX Health Care
  • COOT
  • Exchange
  • LEXX Nasdaq
  • COOT NYSE
  • Market Cap
  • LEXX 20.9M
  • COOT 20.2M
  • IPO Year
  • LEXX N/A
  • COOT N/A
  • Fundamental
  • Price
  • LEXX $0.98
  • COOT $0.83
  • Analyst Decision
  • LEXX Strong Buy
  • COOT
  • Analyst Count
  • LEXX 1
  • COOT 0
  • Target Price
  • LEXX $7.00
  • COOT N/A
  • AVG Volume (30 Days)
  • LEXX 90.9K
  • COOT 29.4K
  • Earning Date
  • LEXX 07-11-2025
  • COOT 01-01-0001
  • Dividend Yield
  • LEXX N/A
  • COOT N/A
  • EPS Growth
  • LEXX N/A
  • COOT N/A
  • EPS
  • LEXX N/A
  • COOT N/A
  • Revenue
  • LEXX $525,923.00
  • COOT $23,640,002.00
  • Revenue This Year
  • LEXX $0.62
  • COOT N/A
  • Revenue Next Year
  • LEXX $14.19
  • COOT N/A
  • P/E Ratio
  • LEXX N/A
  • COOT N/A
  • Revenue Growth
  • LEXX 29.95
  • COOT 16.10
  • 52 Week Low
  • LEXX $0.95
  • COOT $0.61
  • 52 Week High
  • LEXX $4.44
  • COOT $1.69
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 37.32
  • COOT 53.20
  • Support Level
  • LEXX $1.00
  • COOT $0.72
  • Resistance Level
  • LEXX $1.05
  • COOT $0.77
  • Average True Range (ATR)
  • LEXX 0.06
  • COOT 0.05
  • MACD
  • LEXX 0.01
  • COOT 0.02
  • Stochastic Oscillator
  • LEXX 18.34
  • COOT 69.33

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD

Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently. Company's edible oil sales comprise of two segments: sales of bulk oils to wholesalers who use it as food ingredients or white labeling; sales of packaged oils as the company's own branding to supermarket channels. Sales of protein meals are bulk sales and mainly distributed to local farmers and feedlots as protein supplements.

Share on Social Networks: